You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Litigation Details for Pfizer Inc. v. Zydus Pharmaceuticals (USA) Inc. (D. Del. 2017)

✉ Email this page to a colleague

« Back to Dashboard

Pfizer Inc. v. Zydus Pharmaceuticals (USA) Inc. (D. Del. 2017)

Docket	⤷ Sign Up	Date Filed	2017-02-14
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Leonard Philip Stark
Jury Demand	None	Referred To
Patents	6,956,041; 6,965,027; 7,091,208; 7,265,221; 7,301,023; RE41,783
Link to Docket	External link to docket

Small Molecule Drugs cited in Pfizer Inc. v. Zydus Pharmaceuticals (USA) Inc.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Biologic Drugs cited in Pfizer Inc. v. Zydus Pharmaceuticals (USA) Inc.

The biologic drug covered by the patents cited in this case is ⤷ Sign Up .

Details for Pfizer Inc. v. Zydus Pharmaceuticals (USA) Inc. (D. Del. 2017)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2019-07-12	133	Notice of Service	Infringement of United States Patent Nos. 6,965,027 and 7,301,023 and Reissue Patent No. RE41,783 filed by C.P… D.Sc., Regarding Infringement of United States Patent No. RE41,783 and (2) Expert Report of Leonard J…February 2017 1:17-cv-00158-GJP 830 Patent None District Court, D. Delaware	External link to document
2019-07-15	134	Notice of Service	Report of Bart Kahr, Ph.D., Regarding U.S. Patent No. 6,965,027; and (3) Opening Expert Report of Katherine…on the Invalidity of the Asserted Claims of U.S. Patent Nos. RE 41,783 and 7,301,023 filed by Cadila Healthcare…February 2017 1:17-cv-00158-GJP 830 Patent None District Court, D. Delaware	External link to document
2019-09-13	141	Notice of Service	Regarding Validity of United States Patent Nos. RE41,783 and 6,965,027, (4) Expert Report of Christopher…Regarding Objective Indicia of Non-Obviousness of Patent No. RE41,783, (2) Expert Report of Stanley B. Cohen…Regarding Objective Indicia of Non-Obviousness of Patent Nos. RE41,783, (3) Responsive Report of Stephen…February 2017 1:17-cv-00158-GJP 830 Patent None District Court, D. Delaware	External link to document
2019-11-11	145	Notice of Service	Invalidity of the Asserted Claims of U.S. Patent Nos. RE 41,783 and 7,301,023; and (5) Reply Expert Report of Ivan…February 2017 1:17-cv-00158-GJP 830 Patent None District Court, D. Delaware	External link to document
2019-12-20	151	Notice of Service	Regarding Objective Indicia of Nonobviousness of Patent No. RE41,783, (3) Reply Expert Report of Stanley B. Cohen…Regarding Objective Indicia of Nonobviousness of Patent No. RE41,783 and (4) Reply Expert Report of Christopher…February 2017 1:17-cv-00158-GJP 830 Patent None District Court, D. Delaware	External link to document
2017-02-14	4		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,965,027 B2; 7,301,023 B2; RE41,783…February 2017 1:17-cv-00158-GJP 830 Patent None District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.